Expression of von Hippel-Lindau tumor suppressor and tumor-associated carbonic anhydrases IX and XII in normal and neoplastic colorectal mucosa

World Journal of Gastroenterology

Volumn 11, Issue 17, 2005, Pages 2616-2625

  Kivela, Antti J ^a   Parkkila, Seppo ^b   Saarnio, Juha ^a   Karttunen, Tuomo J ^a   Kivela, Jyrki ^c   Parkkila, Anna Kaisa ^d   Bartosova, Maria ^e   Mucha, Vojtech ^e   Novak, Michal ^f   Waheed, Abdul ^g   Sly, William S ^g   Rajaniemi, Hannu ^a   Pastorekova, Silvia ^e   Pastorek, Jaromir ^e  

^a UNIVERSITY OF OULU   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

^e INSTITUTE OF VIROLOGY   (Slovakia)

^f INSTITUTE OF NEUROIMMUNOLOGY   (Slovakia)

^g SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carbonic anhydrase; Colorectal cancer; VEGF; VHL

Indexed keywords

CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE 12; CARBONATE DEHYDRATASE IX; MESSENGER RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; COLORECTAL TUMOR; CONTROLLED STUDY; CORRELATION FUNCTION; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE;

EID: 21044435933     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i17.2616     Document Type: Article

References (59)

1. Sly WS, Hu PY. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem 1995; 64: 375-401
2. Zavada J, Zavadova Z, Pastorekova S, Ciampor F, Pastorek J, Zelnik V. Expression of MaTu-MN protein in human tumor cultures and in clinical specimens. Int J Cancer 2003; 54: 268-274
3. Pastorek J, Pastorekova. S, Callebaut I, Mornon JP, Zelnik V, Opavsky R, Zatovicova M, Liao S, Portetelle D, Stanbridge EJ, Zavada J, Burny A, Kettmann R. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 1994; 9: 2788-2888
4. Opavsky R, Pastorekova S, Zelnik V, Gibadulinova A, Stanbridge EJ, Zavada J, Kettmann R, Pastorek J. Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationship. Genomics 1996; 33: 480-487
5. Tüireci O, Sahin U, Vollmar E, Siemer S, Göttert E, Seitz G, Parkkila AK, Shah GN, Grubb JH, Pfreundschuh M, Sly WS. Human carbonic anhydrase XII: cDNA cloning, expression and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cancers. Proc Natl Acad Sci USA 1998; 95: 7608-7613
6. Ivanov SV, Kuzmin I, Wie MH, Pack S, Geil L, Johnson BE, Stanbridge EJ, Lerman MI. Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc Natl Acad Sci USA 1998; 95: 12596-12601
7. Saarnio J, Parkkila S, Parkkila AK, Haukipuro K, Pastorekova S, Pastorek J, Kairaluoma MI, Karttunen TJ. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am J Pathol 1998; 153: 279-285
8. Kivelä A, Parkkila S, Saarnio J, Karttunen TJ, Kivelä J, Parkkila AK, Waheed A, Sly WS, Grubb JH, Shah G, Türeci Ö, Rajaniemi H. Expression of a novel transmembrane carbonic anhydrase isozyme XII in normal human gut and colorectal tumors. Am J Pathol 2000; 156: 577-584
9. Parkkila S, Rajaniemi H, Parkkila AK, Kivelä J, Waheed A, Pastorekova S, Pastorek J, Sly WS. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci USA 2000; 97: 2220-2224
10. Svastova E, Hulikova A, Rafajova M, Zatovicova M, Gibadulinova A, Casini A, Cecchi A, Scozzafava A, Supuran CT, Pastorek J, Pastorekova S. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett 2004; 577: 439-445
11. Supuran CT, Scozzafava A. Carbonic anhydrase inhibitors - Part 94. 1,2,4-Thiadiazole-2-sulfonamide derivatives as antitumor agents? Eur J Med Chem 2000; 35: 867-874
12. Supuran CT. Indisulam: an anticancer sulfonamide in clinical development. Expert Opin Investig Drugs 2003; 12: 283-287
13. Svastova E, Zilka N, Zatovicova M, Gibadulinova A, Ciampor F, Pastorek J, Pastorekova S. Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with b-catenin. Exp Cell Res 2003; 290: 332-345
14. Wykoff CC, Beasley NJP, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL. Hypoxia inducible regulation of tumor associated carbonic anhydrases. Cancer Res 2000; 60: 7075-7083
15. Potter CPS, Harris AL. Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer. Br J Cancer 2003; 89: 2-7
16. Wykoff CC, Beasley N, Watson PH, Campo L, Chia SK, English R, Pastorek J, Sly WS, Ratcliffe P, Harris AL. Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast. Am J Pathol 2001; 158: 1011-1019
17. Ivanov S, Liao SY, Ivanova A, Danilkovich-Miagkova A, Tarasova N, Weirich G, Merrill MJ, Proescholdt MA, Oldfield EH, Lee J, Zavada J, Waheed A, Sly W, Lerman MI, Stanbridge EJ. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol 2001; 158: 905-919
18. Watson PH, Chia SK, Wykoff CC, Han C, Leek RD, Sly WS, Gatter KC, Ratcliffe P, Harris AL. Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma. Br J Cancer 2003; 88: 1065-1070
19. Pastorekova S, Pastorek J. Cancer-related carbonic anhydrase isozymes and their inhibition. In: Supuran CT, Scozzafava A, Conway J, eds. Carbonic Anhydrase, its Inhibitors and Activators. CRC Press Boca Raton London New York Washington DC 2004: 253-272
20. Ohh M, Kaelin WG Jr. the von Hippel-Lindau tumour suppressor protein: new perspectives. Mol Med Today 1999; 5: 257-263
21. Semenza GL. Targeting HIF-1 for cancer therapy. Nature Rev Cancer 2003; 3: 721-732
22. Kaelin WG Jr. Molecular Basis of the VHL hereditary cancer syndrome. Nature Rev Cancer 2002; 2: 673-682
23. Karumanchi SA, Jiang L, Knebelmann B, Stuart-Tilley AK, Alper SL, Sukhatme VP. VHL tumor suppressor regulates Cl-/HCO3- exchange and Na+/H+ exchange activities in renal carcinoma cells. Physiol Genomics 2001; 5: 119-128
24. Sterling D, Reithmeier RA, Casey JR. A transport metabolon. Functional interaction of carbonic anhydrase II and chloride/bicarbonate exchangers. J Biol Chem 2001; 276: 47886-47894
25. Sterling D, Alvarez BV, Casey JR. The extracellular component of a transport metabolon. Extracellular loop 4 of the human AE1 Cl-/HCO3- exchanger binds carbonic anhydrase IV. J Biol Chem 2002; 277: 25239-25246
26. Liao SY, Aurelio ON, Jan K, Zavada J, Stanbridge EJ. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res 1997; 57: 2827-2831
27. McKiernan JM, Buttyan R, Bander NH, Stifelman MD, Katz AE, Olsson CA, Sawczuk IS. Expression of the tumour-associated gene MN: a potential biomarker for human renal cell carcinoma. Cancer Res 1997; 57: 2362-2365
28. Parkkila S, Parkkila AK, Saarnio J, Kivelä J, Karttunen TJ, Kaunisto K, Waheed A, Sly WS, Türeci Ö, Virtanen I, Rajaniemi H. Expression of the membrane-associated carbonic anhydrase isozyme XII in the human kidney and renal tumors. J Histochem Cytochem 2000; 48: 1601-1608
29. Saarnio J, Parkkila S, Parkkila AK, Waheed A, Casey MC, Zhou XY, Pastorekova S, Pastorek J, Karttunen T, Haukipuro K, Kairaluoma MI, Sly WS. Immunohistochemistry of carbonic anhydrase isozyme IX (MN/CA IX) in human gut reveals polarized expression in the epithelial cells with the highest proliferative capacity. J Histochem Cytochem 1998; 46: 497-504
30. Sakashita N, Takeya M, Kishida T, Stackhouse TM, Zbar B, Takahashi K. Expression of von Hippel-Lindau protein in normal and pathological human tissues. Histochem J 1999; 31: 133-144
31. Zhuang Z, Emmert-Buck MR, Roth MJ, Gnarra J, Linehan WM, Liotta LA, Lubensky IA. von Hippel-Lindau disease gene deletion detected in microdissected sporadic human colon carcinoma specimens. Hum Pathol 1996; 27: 152-156
32. Miyakis S, Sourvinos G, Liloglou TL, Stathopoulos GP, Field JK, Spandidos DA. The von Hippel-Lindau (VHL) tumorsuppressor gene is not mutated in sporadic human colon adenocarcinomas. Int J Cancer 2000; 88: 503-505
33. Pastorekova S, Zavadova Z, Kostal M, Babusikova O, Zavada J. A novel quasi-viral agent, MaTu, is a two-component system. Virology 1992; 187: 620-626
34. Karhumaa P, Parkkila S, Türeci Ö, Waheed A, Grubb JH, Shah G, Parkkila AK, Kaunisto K, Tapanainen J, Sly WS, Rajaniemi H. Identification of carbonic anhydrase XII as the membrane isozyme expressed in the normal human endometrial epithelium. Mol Hum Reprod 2000; 6: 68-74
35. Nuorva K, Soini Y, Kamel D, Autio-Harmainen H, Risteli L, Risteli J, Vähäkangas K, Pääkkö P. Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas. Am J Pathol 1993; 142: 725-732
36. Kuwai T, Kitadai Y, Tanaka S, Onogawa S, Matsutani N, Kaio E, Ito M, Chayama K. Expression of hypoxia-inducible factor-1a is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer 2003; 105: 176-181
37. Kim W, Kaelin WG Jr. The von Hippel-Lindau tumor suppressor protein: new insights into oxygen sensing and cancer. Current Opin Gen Dev 2003; 13: 1-6
38. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykof CC, Pugh CW, Maher ER, Ratcliffe PJ. The tumour suppressor protein VHL targets hypoxia inducible factors for oxygen-dependent proteolysis. Nature 1999; 399: 271-275
39. 2 sensing. Science 2001; 292: 464-468
40. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, von Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ. Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001; 292: 468-472
41. Shiao YH, Ramakrishna G, Anderson LM, Perantoni AO, Rice JM, Diwan BA. Down-regulation of von-Hippel Lindau protein in N-nitroso compound-induced rat non-clear cell renal tumors. Cancer Lett 2002; 179: 33-38
42. Shiao YH, Forsti A, Egevad L, Anderson LM, Lindblad P, Hemminki K. VHL down-regulation and differential localization as mechanisms in tumorigenesis. Kidney Int 2003; 64: 1671-1674
43. Tsutsumi H, Miyamoto C, Furuichi Y, Yoshiike M, Nozawa S, Iwamoto T. VHL tumor suppressor gene: its mutation and protein level in renal cell carcinoma. Oncol Rep 2003; 10: 1357-1361
44. Hinze R, Boltze C, Meye A, Holzhausen HJ, Dralle H, Rath FW. Expression of the von Hippel-Lindau tumor suppressor gene in noneoplastic and neoplastic lesions of the thyroid. Endocr Pathol 2000; 11: 145-155
45. Ashida S, Nishimori I, Tanimura M, Onishi S, Shuin T. Effects of von Hippel-Lindau gene mutation and methylation status on expression of transmembrane carbonic anhydrases in renal cell carcinoma. J Cancer Res Clin Oncol 2002; 128: 561-568
46. Mandriota SJ, Turner KJ, Davies DR, Murray PG, Morgan NV, Sowter HM, Wykoff CC, Maher ER, Harris AL, Ratcliffe PJ, Maxwell PH. HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron. Cancer Cell 2002; 1: 459-468
47. Pastorekova S, Parkkila S, Parkkila AK, Opavsky R, Zelnik V, Saarnio J, Pastorek J. Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementery DNA sequence and expression in human and rat alimentary tracts. Gastroenterology 1997; 112: 398-408
48. Giatromanolaki A, Koukourakis MI, Sivridis E, Pastorek J, Wykoff CC, Gatter KC, Harris AL. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res 2001; 61: 7992-7998
49. Turner KJ, Crew JP, Wykoff CC, Watson PH, Poulsom R, Pastorek J, Ratcliffe PJ, Cranston D, Harris AL. The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer. Br J Cancer 2002; 86: 1276-1282
50. Rafajova M, Zatovicova M, Kettmann R, Pastorek J, Pastorekova S. Induction by hypoxia combined with low glucose or low bicarbonate and high posttranslationla stability upon reoxygenation contribute to carbonic anhydrase IX expression in cancer cells. Int J Oncol 2004; 24: 995-1004
51. Lieskovska J, Opavsky R, Zacikova L, Glasova M, Pastorek J, Pastorekova S. Study of in vitro conditions modulating expression of MN/CA IX protein in human cell lines derived from cervical carcinoma. Neoplasma 1997; 46: 17-24
52. Kaluz S, Kaluzova M, Chrastina A, Olive PL, Pastorekova S, Pastorek J, Lerman MI, Stanbridge EJ. Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1a stabilization: a role for phosphatidylinositol 3′-kinase. Cancer Res 2002; 62: 4469-4477
53. Koura AN, Liu W, Kitadai Y, Singh RK, Radinsky R, Ellis LM. Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by cell density. Cancer Res 1996; 56: 3891-3894
54. Mukhopadhyay D, Tsiokas L, Sukhatme VP. High cell density induces vascular endothelial growth factor expression via protein tyrosine phosphorylation. Gene Expr 1998; 7: 53-60
55. Shweiki D, Neeman M, Itin A, Keshet E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis. Proc Natl Acad Sci USA 1995; 92: 768-772
56. Mukhopadhyay D, Tsiokas L, Zhou XM, Foster D, Brugge JS, Sukhatme VP. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 1995; 375: 577-581
57. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996; 16: 4604-4613
58. Rak J, Mitsuhashi Y, Sheehan C, Tamir A, Viloria-Petit A, Filmus J, Mansour SJ, Ahn NG, Kerbel RS. Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts. Cancer Res 2000; 60: 490-498
59. Toi M, Matsumoto T, Bando H. Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications. Lancet Oncol 2001; 2: 667-673